Share Price and Basic Stock Data
Last Updated: January 8, 2026, 7:03 pm
| PEG Ratio | -105.95 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
UltraTech Cement Ltd, a major player in the Indian cement industry, reported a market capitalization of ₹3,59,037 Cr and a share price of ₹12,184. The company demonstrated robust revenue growth, with sales of ₹63,240 Cr for the year ending March 2023, which rose to ₹70,908 Cr by March 2024, and is projected to reach ₹75,955 Cr in March 2025. The latest quarterly sales figures show a slight decline to ₹16,012 Cr in September 2023, but a strong rebound is expected as sales rose to ₹20,419 Cr by March 2024. The company’s operational efficiency is reflected in its operating profit margin (OPM), which stood at 17% for the year ending March 2023 and is projected to stabilize around 17% for March 2025. The consistent revenue growth positions UltraTech favorably within the sector, particularly as demand for construction materials remains resilient amid infrastructure development initiatives in India.
Profitability and Efficiency Metrics
UltraTech Cement’s profitability metrics indicate a solid financial foundation, with a net profit of ₹7,297 Cr and an impressive return on equity (ROE) of 9.29%. The company recorded an interest coverage ratio (ICR) of 8.06x, illustrating its capacity to manage interest obligations effectively. The operating profit for the latest fiscal year stood at ₹10,620 Cr, while the operating profit margin (OPM) has fluctuated, achieving a high of 20% in March 2024. The company reported a net profit margin of 8.01% in March 2023, which is expected to be around 7.96% for March 2025. These profitability metrics are critical to sustaining investor confidence, especially in a competitive sector where margins can be tight. However, the decline in OPM over the years reflects increasing cost pressures, indicating a need for strategic cost management to maintain profitability.
Balance Sheet Strength and Financial Ratios
UltraTech Cement’s balance sheet reveals significant strength, with total assets reaching ₹133,632 Cr as of March 2025. The company reported total borrowings of ₹25,215 Cr, maintaining a healthy debt-to-equity ratio of 0.32, suggesting prudent financial leverage. Reserves have increased notably from ₹54,036 Cr in March 2023 to ₹70,412 Cr in March 2025, indicating a solid retention of earnings. The book value per share, inclusive of revaluation reserves, stood at ₹2,399.42, reflecting strong shareholder equity. Furthermore, the current ratio of 0.73 indicates potential liquidity challenges, as it is below the typical threshold of 1.0. However, the interest coverage ratio of 8.06x showcases the company’s ability to cover interest expenses, which is a positive sign for creditors and investors alike. These financial ratios underscore UltraTech’s robust position amidst the fluctuating market dynamics of the cement industry.
Shareholding Pattern and Investor Confidence
As of September 2025, UltraTech Cement’s shareholding structure shows a stable distribution, with promoters holding 59.23% of the equity. Foreign institutional investors (FIIs) accounted for 15.33%, while domestic institutional investors (DIIs) held 16.65%, reflecting a balanced interest from both domestic and international investors. The public shareholding stands at 8.55%, indicating a relatively concentrated ownership. The gradual increase in promoter holding from 59.96% in December 2022 to 60.00% in December 2024 may signal confidence in the company’s long-term strategy. However, the recent decline in FIIs from a high of 18.20% in December 2023 to 15.33% in September 2025 could raise concerns about diminishing foreign investor interest. Overall, the shareholding pattern suggests a solid foundation for investor confidence, although monitoring changes in institutional holdings will be crucial going forward.
Outlook, Risks, and Final Insight
Looking ahead, UltraTech Cement stands poised for growth, supported by strong infrastructure spending in India and a favorable market environment. However, the company faces risks, including rising input costs and potential volatility in cement prices. The reported decline in quarterly sales figures indicates that demand may be subject to seasonal fluctuations, which could impact revenue consistency. Furthermore, the company’s reliance on debt financing, with borrowings at ₹25,215 Cr, poses a risk if interest rates rise significantly. On the positive side, UltraTech’s strong operational metrics and solid balance sheet provide a cushion against economic downturns. In a scenario of stable demand and effective cost management, UltraTech could enhance profitability and shareholder returns, whereas adverse economic conditions could challenge its growth trajectory. The company’s performance will be closely monitored as it navigates these challenges while capitalizing on growth opportunities in the evolving construction landscape.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Bheema Cements Ltd | 52.7 Cr. | 16.2 | 19.5/16.2 | 0.60 | 0.00 % | 13.1 % | 108 % | 10.0 | |
| UltraTech Cement Ltd | 3,55,459 Cr. | 12,064 | 13,102/10,048 | 48.5 | 2,444 | 0.64 % | 10.9 % | 9.29 % | 10.0 |
| The Ramco Cements Ltd | 25,587 Cr. | 1,082 | 1,209/788 | 133 | 322 | 0.18 % | 4.83 % | 1.56 % | 1.00 |
| The India Cements Ltd | 14,757 Cr. | 476 | 486/239 | 325 | 0.00 % | 5.49 % | 8.83 % | 10.0 | |
| Star Cement Ltd | 8,962 Cr. | 222 | 309/196 | 29.6 | 74.4 | 0.45 % | 8.39 % | 6.05 % | 1.00 |
| Industry Average | 38,104.38 Cr | 1,939.11 | 37.61 | 573.47 | 0.54% | 8.79% | 85.81% | 7.13 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 13,893 | 15,521 | 18,662 | 17,737 | 16,012 | 16,740 | 20,419 | 18,819 | 16,294 | 17,779 | 23,063 | 21,275 | 19,607 |
| Expenses | 12,028 | 13,185 | 15,340 | 14,688 | 13,461 | 13,485 | 16,305 | 15,801 | 14,269 | 14,885 | 18,456 | 16,869 | 16,518 |
| Operating Profit | 1,865 | 2,336 | 3,322 | 3,049 | 2,551 | 3,255 | 4,114 | 3,017 | 2,026 | 2,893 | 4,608 | 4,406 | 3,089 |
| OPM % | 13% | 15% | 18% | 17% | 16% | 19% | 20% | 16% | 12% | 16% | 20% | 21% | 16% |
| Other Income | 146 | 130 | 123 | 177 | 171 | 146 | 73 | 83 | 226 | 247 | 93 | 142 | 174 |
| Interest | 200 | 215 | 191 | 211 | 234 | 262 | 261 | 326 | 393 | 457 | 475 | 433 | 459 |
| Depreciation | 708 | 723 | 762 | 749 | 798 | 783 | 815 | 918 | 980 | 993 | 1,125 | 1,107 | 1,148 |
| Profit before tax | 1,103 | 1,527 | 2,492 | 2,267 | 1,690 | 2,355 | 3,111 | 1,857 | 879 | 1,691 | 3,101 | 3,008 | 1,656 |
| Tax % | 31% | 30% | 33% | 25% | 24% | 25% | 27% | 20% | 19% | 19% | 20% | 26% | 25% |
| Net Profit | 759 | 1,063 | 1,670 | 1,690 | 1,280 | 1,775 | 2,259 | 1,493 | 708 | 1,363 | 2,475 | 2,221 | 1,238 |
| EPS in Rs | 26.18 | 36.66 | 57.71 | 58.49 | 44.39 | 61.55 | 78.22 | 51.78 | 24.34 | 47.09 | 84.23 | 75.54 | 41.79 |
Last Updated: December 28, 2025, 5:35 pm
Below is a detailed analysis of the quarterly data for UltraTech Cement Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 19,607.00 Cr.. The value appears to be declining and may need further review. It has decreased from 21,275.00 Cr. (Jun 2025) to 19,607.00 Cr., marking a decrease of 1,668.00 Cr..
- For Expenses, as of Sep 2025, the value is 16,518.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 16,869.00 Cr. (Jun 2025) to 16,518.00 Cr., marking a decrease of 351.00 Cr..
- For Operating Profit, as of Sep 2025, the value is 3,089.00 Cr.. The value appears to be declining and may need further review. It has decreased from 4,406.00 Cr. (Jun 2025) to 3,089.00 Cr., marking a decrease of 1,317.00 Cr..
- For OPM %, as of Sep 2025, the value is 16.00%. The value appears to be declining and may need further review. It has decreased from 21.00% (Jun 2025) to 16.00%, marking a decrease of 5.00%.
- For Other Income, as of Sep 2025, the value is 174.00 Cr.. The value appears strong and on an upward trend. It has increased from 142.00 Cr. (Jun 2025) to 174.00 Cr., marking an increase of 32.00 Cr..
- For Interest, as of Sep 2025, the value is 459.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 433.00 Cr. (Jun 2025) to 459.00 Cr., marking an increase of 26.00 Cr..
- For Depreciation, as of Sep 2025, the value is 1,148.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,107.00 Cr. (Jun 2025) to 1,148.00 Cr., marking an increase of 41.00 Cr..
- For Profit before tax, as of Sep 2025, the value is 1,656.00 Cr.. The value appears to be declining and may need further review. It has decreased from 3,008.00 Cr. (Jun 2025) to 1,656.00 Cr., marking a decrease of 1,352.00 Cr..
- For Tax %, as of Sep 2025, the value is 25.00%. The value appears to be improving (decreasing) as expected. It has decreased from 26.00% (Jun 2025) to 25.00%, marking a decrease of 1.00%.
- For Net Profit, as of Sep 2025, the value is 1,238.00 Cr.. The value appears to be declining and may need further review. It has decreased from 2,221.00 Cr. (Jun 2025) to 1,238.00 Cr., marking a decrease of 983.00 Cr..
- For EPS in Rs, as of Sep 2025, the value is 41.79. The value appears to be declining and may need further review. It has decreased from 75.54 (Jun 2025) to 41.79, marking a decrease of 33.75.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 4:27 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 20,730 | 23,306 | 25,153 | 25,375 | 30,979 | 41,462 | 42,430 | 44,726 | 52,599 | 63,240 | 70,908 | 75,955 | 81,725 |
| Expenses | 16,695 | 18,881 | 20,252 | 20,162 | 24,834 | 34,115 | 33,184 | 33,158 | 41,084 | 52,620 | 57,930 | 63,158 | 66,729 |
| Operating Profit | 4,035 | 4,425 | 4,901 | 5,212 | 6,145 | 7,347 | 9,246 | 11,568 | 11,514 | 10,620 | 12,979 | 12,797 | 14,996 |
| OPM % | 19% | 19% | 19% | 21% | 20% | 18% | 22% | 26% | 22% | 17% | 18% | 17% | 18% |
| Other Income | 322 | 350 | 464 | 648 | 242 | 350 | 651 | 619 | 669 | 507 | 557 | 397 | 656 |
| Interest | 361 | 587 | 566 | 640 | 1,238 | 1,778 | 1,992 | 1,486 | 945 | 823 | 968 | 1,651 | 1,824 |
| Depreciation | 1,139 | 1,203 | 1,377 | 1,348 | 1,848 | 2,451 | 2,723 | 2,700 | 2,715 | 2,888 | 3,145 | 4,015 | 4,372 |
| Profit before tax | 2,858 | 2,986 | 3,421 | 3,872 | 3,301 | 3,468 | 5,183 | 8,001 | 8,524 | 7,416 | 9,422 | 7,528 | 9,456 |
| Tax % | 23% | 30% | 28% | 30% | 33% | 31% | -11% | 32% | 14% | 32% | 26% | 20% | |
| Net Profit | 2,213 | 2,102 | 2,480 | 2,714 | 2,224 | 2,400 | 5,751 | 5,462 | 7,334 | 5,073 | 7,004 | 6,040 | 7,297 |
| EPS in Rs | 80.44 | 76.47 | 90.30 | 98.90 | 80.92 | 87.51 | 199.40 | 189.26 | 254.42 | 175.41 | 242.65 | 204.94 | 248.65 |
| Dividend Payout % | 11% | 12% | 11% | 10% | 13% | 13% | 7% | 20% | 15% | 22% | 29% | 38% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -5.02% | 17.98% | 9.44% | -18.05% | 7.91% | 139.62% | -5.03% | 34.27% | -30.83% | 38.06% | -13.76% |
| Change in YoY Net Profit Growth (%) | 0.00% | 23.00% | -8.55% | -27.49% | 25.97% | 131.71% | -144.65% | 39.30% | -65.10% | 68.89% | -51.83% |
UltraTech Cement Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 13% |
| 5 Years: | 12% |
| 3 Years: | 13% |
| TTM: | 8% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 12% |
| 5 Years: | 1% |
| 3 Years: | -5% |
| TTM: | 0% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 16% |
| 5 Years: | 26% |
| 3 Years: | 25% |
| 1 Year: | 10% |
| Return on Equity | |
|---|---|
| 10 Years: | 12% |
| 5 Years: | 12% |
| 3 Years: | 10% |
| Last Year: | 9% |
Last Updated: September 5, 2025, 1:50 pm
Balance Sheet
Last Updated: December 10, 2025, 3:35 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 274 | 274 | 274 | 275 | 275 | 275 | 289 | 289 | 289 | 289 | 289 | 295 | 295 |
| Reserves | 16,908 | 18,767 | 21,671 | 24,117 | 26,107 | 33,476 | 38,755 | 43,886 | 50,147 | 54,036 | 59,939 | 70,412 | 71,738 |
| Borrowings | 7,332 | 9,829 | 10,616 | 8,474 | 19,480 | 25,337 | 23,019 | 21,719 | 11,299 | 11,058 | 11,403 | 24,102 | 25,215 |
| Other Liabilities | 7,671 | 9,183 | 8,631 | 9,343 | 11,280 | 17,438 | 17,151 | 20,282 | 22,077 | 25,998 | 29,167 | 38,823 | 40,058 |
| Total Liabilities | 32,185 | 38,053 | 41,193 | 42,209 | 57,141 | 76,525 | 79,214 | 86,176 | 83,811 | 91,380 | 100,797 | 133,632 | 137,305 |
| Fixed Assets | 18,100 | 23,343 | 25,309 | 25,904 | 39,715 | 56,645 | 57,151 | 55,412 | 55,488 | 59,579 | 62,878 | 94,564 | 95,930 |
| CWIP | 2,186 | 2,250 | 1,469 | 921 | 1,511 | 1,153 | 920 | 1,687 | 4,785 | 4,040 | 6,811 | 6,234 | 7,206 |
| Investments | 4,862 | 4,500 | 5,095 | 6,691 | 5,447 | 2,921 | 5,929 | 12,178 | 6,336 | 7,297 | 8,249 | 5,156 | 5,098 |
| Other Assets | 7,037 | 7,961 | 9,319 | 8,693 | 10,468 | 15,806 | 15,215 | 16,900 | 17,203 | 20,464 | 22,859 | 27,677 | 29,072 |
| Total Assets | 32,185 | 38,053 | 41,193 | 42,209 | 57,141 | 76,525 | 79,214 | 86,176 | 83,811 | 91,380 | 100,797 | 133,632 | 137,305 |
Below is a detailed analysis of the balance sheet data for UltraTech Cement Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 295.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 295.00 Cr..
- For Reserves, as of Sep 2025, the value is 71,738.00 Cr.. The value appears strong and on an upward trend. It has increased from 70,412.00 Cr. (Mar 2025) to 71,738.00 Cr., marking an increase of 1,326.00 Cr..
- For Borrowings, as of Sep 2025, the value is 25,215.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 24,102.00 Cr. (Mar 2025) to 25,215.00 Cr., marking an increase of 1,113.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 40,058.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 38,823.00 Cr. (Mar 2025) to 40,058.00 Cr., marking an increase of 1,235.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 137,305.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 133,632.00 Cr. (Mar 2025) to 137,305.00 Cr., marking an increase of 3,673.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 95,930.00 Cr.. The value appears strong and on an upward trend. It has increased from 94,564.00 Cr. (Mar 2025) to 95,930.00 Cr., marking an increase of 1,366.00 Cr..
- For CWIP, as of Sep 2025, the value is 7,206.00 Cr.. The value appears strong and on an upward trend. It has increased from 6,234.00 Cr. (Mar 2025) to 7,206.00 Cr., marking an increase of 972.00 Cr..
- For Investments, as of Sep 2025, the value is 5,098.00 Cr.. The value appears to be declining and may need further review. It has decreased from 5,156.00 Cr. (Mar 2025) to 5,098.00 Cr., marking a decrease of 58.00 Cr..
- For Other Assets, as of Sep 2025, the value is 29,072.00 Cr.. The value appears strong and on an upward trend. It has increased from 27,677.00 Cr. (Mar 2025) to 29,072.00 Cr., marking an increase of 1,395.00 Cr..
- For Total Assets, as of Sep 2025, the value is 137,305.00 Cr.. The value appears strong and on an upward trend. It has increased from 133,632.00 Cr. (Mar 2025) to 137,305.00 Cr., marking an increase of 3,673.00 Cr..
Notably, the Reserves (71,738.00 Cr.) exceed the Borrowings (25,215.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -3.00 | -5.00 | -6.00 | -3.00 | -13.00 | -18.00 | -14.00 | -10.00 | 0.00 | -1.00 | 1.00 | -12.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 29 | 26 | 28 | 25 | 26 | 25 | 20 | 21 | 21 | 22 | 22 | 28 |
| Inventory Days | 251 | 266 | 203 | 195 | 226 | 214 | 234 | 207 | 256 | 248 | 255 | 255 |
| Days Payable | 252 | 154 | 142 | 150 | 165 | 165 | 188 | 234 | 269 | 271 | 260 | 248 |
| Cash Conversion Cycle | 28 | 138 | 89 | 70 | 87 | 74 | 66 | -6 | 9 | -0 | 17 | 35 |
| Working Capital Days | -20 | -82 | -83 | -38 | -50 | -48 | -60 | -83 | -56 | -56 | -52 | -64 |
| ROCE % | 12% | 12% | 13% | 14% | 12% | 10% | 12% | 15% | 14% | 13% | 15% | 11% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| ICICI Prudential Large Cap Fund | 2,103,927 | 3.12 | 2440.56 | 2,135,713 | 2025-12-15 08:36:05 | -1.49% |
| Kotak Flexicap Fund | 1,375,000 | 2.8 | 1595 | N/A | N/A | N/A |
| Axis Large Cap Fund | 826,535 | 2.81 | 958.78 | 843,367 | 2025-12-15 08:36:05 | -2% |
| Axis ELSS Tax Saver Fund | 697,445 | 2.31 | 809.04 | N/A | N/A | N/A |
| Nippon India Large Cap Fund | 625,475 | 1.44 | 725.55 | N/A | N/A | N/A |
| ICICI Prudential Business Cycle Fund | 395,118 | 2.92 | 458.34 | 401,113 | 2025-12-15 08:36:05 | -1.49% |
| ICICI Prudential Equity & Debt Fund | 390,187 | 0.92 | 452.62 | N/A | N/A | N/A |
| ICICI Prudential Multicap Fund | 368,008 | 2.64 | 426.89 | N/A | N/A | N/A |
| Kotak Large & Midcap Fund | 330,000 | 1.28 | 382.8 | N/A | N/A | N/A |
| HDFC Large Cap Fund | 324,934 | 0.93 | 376.92 | N/A | N/A | N/A |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 205.30 | 243.05 | 175.63 | 254.64 | 189.40 |
| Diluted EPS (Rs.) | 205.13 | 242.87 | 175.54 | 254.53 | 189.33 |
| Cash EPS (Rs.) | 341.56 | 350.80 | 275.64 | 348.06 | 282.69 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 2399.42 | 2086.23 | 1883.69 | 1747.05 | 1530.59 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 2399.42 | 2086.23 | 1883.69 | 1747.05 | 1530.59 |
| Revenue From Operations / Share (Rs.) | 2577.55 | 2456.20 | 2190.58 | 1822.11 | 1549.48 |
| PBDIT / Share (Rs.) | 451.39 | 470.59 | 385.29 | 416.47 | 426.19 |
| PBIT / Share (Rs.) | 315.14 | 361.64 | 285.25 | 322.42 | 332.65 |
| PBT / Share (Rs.) | 255.83 | 325.62 | 256.75 | 289.70 | 272.14 |
| Net Profit / Share (Rs.) | 205.31 | 241.85 | 175.60 | 254.01 | 189.14 |
| NP After MI And SOA / Share (Rs.) | 204.94 | 242.65 | 175.41 | 254.42 | 189.26 |
| PBDIT Margin (%) | 17.51 | 19.15 | 17.58 | 22.85 | 27.50 |
| PBIT Margin (%) | 12.22 | 14.72 | 13.02 | 17.69 | 21.46 |
| PBT Margin (%) | 9.92 | 13.25 | 11.72 | 15.89 | 17.56 |
| Net Profit Margin (%) | 7.96 | 9.84 | 8.01 | 13.94 | 12.20 |
| NP After MI And SOA Margin (%) | 7.95 | 9.87 | 8.00 | 13.96 | 12.21 |
| Return on Networth / Equity (%) | 8.54 | 11.63 | 9.32 | 14.56 | 12.36 |
| Return on Capital Employeed (%) | 9.16 | 14.12 | 12.11 | 14.61 | 14.63 |
| Return On Assets (%) | 4.51 | 6.94 | 5.54 | 8.76 | 6.33 |
| Long Term Debt / Equity (X) | 0.22 | 0.08 | 0.09 | 0.10 | 0.30 |
| Total Debt / Equity (X) | 0.32 | 0.17 | 0.18 | 0.20 | 0.40 |
| Asset Turnover Ratio (%) | 0.64 | 0.73 | 0.71 | 0.60 | 0.54 |
| Current Ratio (X) | 0.73 | 0.86 | 0.88 | 0.86 | 1.17 |
| Quick Ratio (X) | 0.43 | 0.55 | 0.60 | 0.59 | 0.97 |
| Inventory Turnover Ratio (X) | 8.49 | 9.49 | 1.46 | 1.41 | 1.31 |
| Dividend Payout Ratio (NP) (%) | 33.40 | 15.63 | 21.57 | 14.52 | 6.86 |
| Dividend Payout Ratio (CP) (%) | 20.06 | 10.78 | 13.74 | 10.60 | 4.59 |
| Earning Retention Ratio (%) | 66.60 | 84.37 | 78.43 | 85.48 | 93.14 |
| Cash Earning Retention Ratio (%) | 79.94 | 89.22 | 86.26 | 89.40 | 95.41 |
| Interest Coverage Ratio (X) | 8.06 | 14.03 | 13.52 | 12.73 | 8.28 |
| Interest Coverage Ratio (Post Tax) (X) | 4.72 | 8.29 | 7.16 | 8.59 | 4.75 |
| Enterprise Value (Cr.) | 363558.87 | 290900.97 | 228788.60 | 200424.86 | 210253.91 |
| EV / Net Operating Revenue (X) | 4.79 | 4.10 | 3.62 | 3.81 | 4.70 |
| EV / EBITDA (X) | 27.33 | 21.41 | 20.57 | 16.67 | 17.09 |
| MarketCap / Net Operating Revenue (X) | 4.46 | 3.97 | 3.48 | 3.62 | 4.35 |
| Retention Ratios (%) | 66.59 | 84.36 | 78.42 | 85.47 | 93.13 |
| Price / BV (X) | 4.79 | 4.67 | 4.05 | 3.78 | 4.40 |
| Price / Net Operating Revenue (X) | 4.46 | 3.97 | 3.48 | 3.62 | 4.35 |
| EarningsYield | 0.01 | 0.02 | 0.02 | 0.03 | 0.02 |
After reviewing the key financial ratios for UltraTech Cement Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 205.30. This value is within the healthy range. It has decreased from 243.05 (Mar 24) to 205.30, marking a decrease of 37.75.
- For Diluted EPS (Rs.), as of Mar 25, the value is 205.13. This value is within the healthy range. It has decreased from 242.87 (Mar 24) to 205.13, marking a decrease of 37.74.
- For Cash EPS (Rs.), as of Mar 25, the value is 341.56. This value is within the healthy range. It has decreased from 350.80 (Mar 24) to 341.56, marking a decrease of 9.24.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 2,399.42. It has increased from 2,086.23 (Mar 24) to 2,399.42, marking an increase of 313.19.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 2,399.42. It has increased from 2,086.23 (Mar 24) to 2,399.42, marking an increase of 313.19.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 2,577.55. It has increased from 2,456.20 (Mar 24) to 2,577.55, marking an increase of 121.35.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 451.39. This value is within the healthy range. It has decreased from 470.59 (Mar 24) to 451.39, marking a decrease of 19.20.
- For PBIT / Share (Rs.), as of Mar 25, the value is 315.14. This value is within the healthy range. It has decreased from 361.64 (Mar 24) to 315.14, marking a decrease of 46.50.
- For PBT / Share (Rs.), as of Mar 25, the value is 255.83. This value is within the healthy range. It has decreased from 325.62 (Mar 24) to 255.83, marking a decrease of 69.79.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 205.31. This value is within the healthy range. It has decreased from 241.85 (Mar 24) to 205.31, marking a decrease of 36.54.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 204.94. This value is within the healthy range. It has decreased from 242.65 (Mar 24) to 204.94, marking a decrease of 37.71.
- For PBDIT Margin (%), as of Mar 25, the value is 17.51. This value is within the healthy range. It has decreased from 19.15 (Mar 24) to 17.51, marking a decrease of 1.64.
- For PBIT Margin (%), as of Mar 25, the value is 12.22. This value is within the healthy range. It has decreased from 14.72 (Mar 24) to 12.22, marking a decrease of 2.50.
- For PBT Margin (%), as of Mar 25, the value is 9.92. This value is below the healthy minimum of 10. It has decreased from 13.25 (Mar 24) to 9.92, marking a decrease of 3.33.
- For Net Profit Margin (%), as of Mar 25, the value is 7.96. This value is within the healthy range. It has decreased from 9.84 (Mar 24) to 7.96, marking a decrease of 1.88.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 7.95. This value is below the healthy minimum of 8. It has decreased from 9.87 (Mar 24) to 7.95, marking a decrease of 1.92.
- For Return on Networth / Equity (%), as of Mar 25, the value is 8.54. This value is below the healthy minimum of 15. It has decreased from 11.63 (Mar 24) to 8.54, marking a decrease of 3.09.
- For Return on Capital Employeed (%), as of Mar 25, the value is 9.16. This value is below the healthy minimum of 10. It has decreased from 14.12 (Mar 24) to 9.16, marking a decrease of 4.96.
- For Return On Assets (%), as of Mar 25, the value is 4.51. This value is below the healthy minimum of 5. It has decreased from 6.94 (Mar 24) to 4.51, marking a decrease of 2.43.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.22. This value is within the healthy range. It has increased from 0.08 (Mar 24) to 0.22, marking an increase of 0.14.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.32. This value is within the healthy range. It has increased from 0.17 (Mar 24) to 0.32, marking an increase of 0.15.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.64. It has decreased from 0.73 (Mar 24) to 0.64, marking a decrease of 0.09.
- For Current Ratio (X), as of Mar 25, the value is 0.73. This value is below the healthy minimum of 1.5. It has decreased from 0.86 (Mar 24) to 0.73, marking a decrease of 0.13.
- For Quick Ratio (X), as of Mar 25, the value is 0.43. This value is below the healthy minimum of 1. It has decreased from 0.55 (Mar 24) to 0.43, marking a decrease of 0.12.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 8.49. This value exceeds the healthy maximum of 8. It has decreased from 9.49 (Mar 24) to 8.49, marking a decrease of 1.00.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 33.40. This value is within the healthy range. It has increased from 15.63 (Mar 24) to 33.40, marking an increase of 17.77.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 20.06. This value is within the healthy range. It has increased from 10.78 (Mar 24) to 20.06, marking an increase of 9.28.
- For Earning Retention Ratio (%), as of Mar 25, the value is 66.60. This value is within the healthy range. It has decreased from 84.37 (Mar 24) to 66.60, marking a decrease of 17.77.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 79.94. This value exceeds the healthy maximum of 70. It has decreased from 89.22 (Mar 24) to 79.94, marking a decrease of 9.28.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 8.06. This value is within the healthy range. It has decreased from 14.03 (Mar 24) to 8.06, marking a decrease of 5.97.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 4.72. This value is within the healthy range. It has decreased from 8.29 (Mar 24) to 4.72, marking a decrease of 3.57.
- For Enterprise Value (Cr.), as of Mar 25, the value is 363,558.87. It has increased from 290,900.97 (Mar 24) to 363,558.87, marking an increase of 72,657.90.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 4.79. This value exceeds the healthy maximum of 3. It has increased from 4.10 (Mar 24) to 4.79, marking an increase of 0.69.
- For EV / EBITDA (X), as of Mar 25, the value is 27.33. This value exceeds the healthy maximum of 15. It has increased from 21.41 (Mar 24) to 27.33, marking an increase of 5.92.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 4.46. This value exceeds the healthy maximum of 3. It has increased from 3.97 (Mar 24) to 4.46, marking an increase of 0.49.
- For Retention Ratios (%), as of Mar 25, the value is 66.59. This value is within the healthy range. It has decreased from 84.36 (Mar 24) to 66.59, marking a decrease of 17.77.
- For Price / BV (X), as of Mar 25, the value is 4.79. This value exceeds the healthy maximum of 3. It has increased from 4.67 (Mar 24) to 4.79, marking an increase of 0.12.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 4.46. This value exceeds the healthy maximum of 3. It has increased from 3.97 (Mar 24) to 4.46, marking an increase of 0.49.
- For EarningsYield, as of Mar 25, the value is 0.01. This value is below the healthy minimum of 5. It has decreased from 0.02 (Mar 24) to 0.01, marking a decrease of 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in UltraTech Cement Ltd:
- Net Profit Margin: 7.96%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 9.16% (Industry Average ROCE: 8.79%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 8.54% (Industry Average ROE: 85.81%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 4.72
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.43
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 48.5 (Industry average Stock P/E: 37.61)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.32
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 7.96%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Cement | 'B' Wing, Ahura Centre, 2nd Foor, Mumbai Maharashtra 400093 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Kumar Mangalam Birla | Chairman & Non-Exe.Director |
| Mr. K K Maheshwari | Vice Chairman & Non Exe.Dire |
| Mr. K C Jhanwar | Managing Director |
| Mrs. Rajashree Birla | Non Executive Director |
| Mrs. Alka Bharucha | Independent Director |
| Mr. Sunil Duggal | Independent Director |
| Mr. Vivek Agrawal | Whole Time Director |
| Mr. Anjani Agrawal | Independent Director |
| Dr. Vikas Balia | Independent Director |
| Ms. Anita Ramachandran | Independent Director |
FAQ
What is the intrinsic value of UltraTech Cement Ltd?
UltraTech Cement Ltd's intrinsic value (as of 08 January 2026) is ₹8865.83 which is 26.51% lower the current market price of ₹12,064.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹3,55,459 Cr. market cap, FY2025-2026 high/low of ₹13,102/10,048, reserves of ₹71,738 Cr, and liabilities of ₹137,305 Cr.
What is the Market Cap of UltraTech Cement Ltd?
The Market Cap of UltraTech Cement Ltd is 3,55,459 Cr..
What is the current Stock Price of UltraTech Cement Ltd as on 08 January 2026?
The current stock price of UltraTech Cement Ltd as on 08 January 2026 is ₹12,064.
What is the High / Low of UltraTech Cement Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of UltraTech Cement Ltd stocks is ₹13,102/10,048.
What is the Stock P/E of UltraTech Cement Ltd?
The Stock P/E of UltraTech Cement Ltd is 48.5.
What is the Book Value of UltraTech Cement Ltd?
The Book Value of UltraTech Cement Ltd is 2,444.
What is the Dividend Yield of UltraTech Cement Ltd?
The Dividend Yield of UltraTech Cement Ltd is 0.64 %.
What is the ROCE of UltraTech Cement Ltd?
The ROCE of UltraTech Cement Ltd is 10.9 %.
What is the ROE of UltraTech Cement Ltd?
The ROE of UltraTech Cement Ltd is 9.29 %.
What is the Face Value of UltraTech Cement Ltd?
The Face Value of UltraTech Cement Ltd is 10.0.